Nicolas Orfanidis has over 20 years of work experience in various finance and leadership roles. Nicolas is currently working as the CFO at Trixell since 2021. Prior to this, they served as the Head of Finance Advanced Therapies for France, Belux, and western Africa Zone at Siemens Healthineers France from 2020 to 2021. In this role, they were actively involved in growth strategy and profitability improvement. Nicolas also held additional roles at Siemens Healthineers, including Head of Business Performance Controlling for the FBA Zone and driving digitalization and new finance organization.
From 2013 to 2020, Nicolas worked at Siemens Healthcare Diagnostics France, where they started as the CFO for the in vitro company in France and later became the Deputy CFO of Siemens Healthineers in France.
Nicolas also served as the Deputy CFO of Division at Siemens Rail Systems France from 2012 to 2013, managing turnkey projects and a team of 24 employees. Prior to that, they worked as the Business Segment CFO for the SWENA area at Siemens Mobility from 2011 to 2012.
Nicolas Orfanidis has extensive experience at Siemens Mobility, where they worked from 2006 to 2012. Nicolas held the role of Business Unit CFO for International projects, leading the finance function for the Rail Automation business unit.
Before joining Siemens Mobility, Nicolas worked at Siemens BenQ Mobile France as a Key Account Manager and acted as the CEO of the company for a period of four months. Nicolas also held roles at Siemens Telecom France as the BU CFO for Products and Projects, managing mobile phones and fixed carrier networks business units respectively.
Nicolas Orfanidis started their career at Siemens Telecom Germany as a Price Manager from 1998 to 1999.
Nicolas Orfanidis pursued their education at the Paris School of Business from 1988 to 1992. During this time, they focused on Finance, specializing in the field of Business. Later on, they joined the HEC School of Management for an Executive MBA Program in 2010, completing it in 2011.
November, 2021 - present